摘要
用3-乙酰吡啶(2)和N,N-二甲基甲酰胺二甲缩醛(3)反应得3-二甲胺基-1-(3-吡啶基)-2-丙烯-1-酮(4),4与2-甲基-5-硝基苯基胍硝酸盐(6)经成环、还原、由4-氯甲基苯甲酰氯酰化后与N-甲基哌嗪反应,所得伊马替尼再成盐即得甲磺酸伊马替尼,总收率约58%(以2计)。
Imatinib mesylate was synthesized by reaction from 3-acetylpyridine(2) and N,N-dimethylformamide dimethyl acetal(3) to give 3-dimethylamino-1-(3-pyridinyl)-2-propylene-1-one(4), which was subjected to cyclization, reduction, acylation with 4-chloromethylbenzoyl chloride and reaction with N-methylpiperazine, followed by salt formation with an overall yield of about 58%(based on 2).
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2013年第7期644-647,共4页
Chinese Journal of Pharmaceuticals
基金
国家自然科学基金(81072529)